Return-Path: Delivered-To: renata@bewonderful.com.br Received: from cloud.mkt.tools by cloud.mkt.tools with LMTP id QZhfAmbQk2dV2j4AaNiWHg (envelope-from ) for ; Fri, 24 Jan 2025 14:39:50 -0300 Return-path: Envelope-to: renata@bewonderful.com.br Delivery-date: Fri, 24 Jan 2025 14:39:50 -0300 Received: from mail-mw2nam10on2080.outbound.protection.outlook.com ([40.107.94.80]:11233 helo=NAM10-MW2-obe.outbound.protection.outlook.com) by cloud.mkt.tools with esmtps (TLS1.3) tls TLS_AES_256_GCM_SHA384 (Exim 4.98) (envelope-from ) id 1tbNeL-0000000HHVA-32Pr for renata@bewonderful.com.br; Fri, 24 Jan 2025 14:39:49 -0300 ARC-Seal: i=1; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=none; b=Ew+CF40rb8J5Jtfp0DPWmTAS3SIeb/HkiHpTImTmVnWzNYMtIO076kbSdjOI9THoTQnwVqqMH82NeA2Tr0VPtnFnxS8XlL9qynrI0oUuADS6SIYGnkHWZR5UixGst52yNQQvtS4PA7PvtkxqSJ7M2SCEkcocukS45/jvXZYMEMbpKPicDJVHgwXHEIgZkf0nXQlYaWaOMywD+ltUW+gNMRoHUnrMkwQr4SzSKICJLthGj5HtG0dnNBZHtldkgjga9JbAqxK4WCIO9lkycYe572BCsXodrVbOYZf+nmvAF4P3nQOrL95icZcJHxtyOCMk0pXL/YSjHhGm804A1XkAmw== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=mp3XBi2717IbUnuZ8KKeMmwUXWv2eWNGd2pDIDqnFps=; b=tPPS84wu/sGABB68IJxteIlTsWFfWJj5+dfn08716E4jh/aINYDqRU5QhxfwTItDp5v9Gm9MN6OOL6qZSeM2ucTY/MYiV1P+hMzq+KRpWOLD1dsQ9Lb9jYHycCBsFnONYqmamperjoHGVi6Tw153VsjDLJ0noS5JJpTxGdmz2DAR5+GVtPvxxTuUbBbdkbTtunpsQo8Es4JZeLHDm3hXBURhOmIqI0hm3NHybsZI1Xbs3Lab0sqNehRSuA24U25BwzPcGD+8lmGv3gqgMgQwjJLeww/sbg8Ui+JIlYyT6z8+k/PJWhRyfOHGWRnmMkdXeFfvr0q9WwbIPr0Z627Ndw== ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=pass smtp.mailfrom=hypera.com.br; dmarc=pass action=none header.from=hypera.com.br; dkim=pass header.d=hypera.com.br; arc=none DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=hypera.com.br; s=selector1; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=mp3XBi2717IbUnuZ8KKeMmwUXWv2eWNGd2pDIDqnFps=; b=SCDFt8efkctRWu1Us8slXhhb5Urx/JgIVsPb9Z9fy16RbkZHLwPlqQAdHBBLlrWcM9wLjA1PoqXPqucjrY2eTI5C9gylYQ56zTbk86crzfBIg5BNvf+ookdmTVux3aQVuyguRgQGXRlCTNTJ9bl3NlVEsrReqoEX9R69DulSKtDYWD6w4mMYK3RPGMsOwzxlJIC5dwPgBnBiITF5ndoelPybfUK0Z6CIx6ua4DBxK7jjoLVtRbrTsO7wiS+Wb3fkoLtBhuUNEWTQ/eAUw5vp1nt72UJutJL9NgDxd4jmMTwZf+YkPoSE+PHkeATHri4SUp+s+pPsesfOaurTQvYe6w== Received: from CPTP152MB4022.LAMP152.PROD.OUTLOOK.COM (2603:10d6:103:fa::13) by CPWP152MB6359.LAMP152.PROD.OUTLOOK.COM (2603:10d6:103:204::15) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.8377.18; Fri, 24 Jan 2025 17:38:50 +0000 Received: from CPTP152MB4022.LAMP152.PROD.OUTLOOK.COM ([fe80::1661:e00:6152:7cfc]) by CPTP152MB4022.LAMP152.PROD.OUTLOOK.COM ([fe80::1661:e00:6152:7cfc%5]) with mapi id 15.20.8356.020; Fri, 24 Jan 2025 17:38:50 +0000 From: Lucas Da Mata Lopes To: Renata de Cristofaro CC: Tatiane Giglioti Subject: =?iso-8859-1?Q?Artes_Mec=E2nicas_Clube_de_Craques_e_EANs_-_Fevereiro?= Thread-Topic: =?iso-8859-1?Q?Artes_Mec=E2nicas_Clube_de_Craques_e_EANs_-_Fevereiro?= Thread-Index: AdtuhV6UiflGIMN4TLSXOWdc/y4yog== Date: Fri, 24 Jan 2025 17:38:50 +0000 Message-ID: Accept-Language: pt-BR, en-US Content-Language: pt-BR X-MS-Has-Attach: yes X-MS-TNEF-Correlator: authentication-results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=hypera.com.br; x-ms-publictraffictype: Email x-ms-traffictypediagnostic: CPTP152MB4022:EE_|CPWP152MB6359:EE_ x-ms-office365-filtering-correlation-id: f7b72a6a-46d9-4ed0-afc2-08dd3c9df6a2 x-ms-exchange-atpmessageproperties: SA x-ms-exchange-senderadcheck: 1 x-ms-exchange-antispam-relay: 0 x-microsoft-antispam: BCL:0;ARA:13230040|376014|366016|1800799024|38070700018|8096899003; x-microsoft-antispam-message-info: =?iso-8859-1?Q?BVzDBpuTfwBVddGm7M38nyJypZe82GYn1sTYalC9ZBEA5xPbMO3UGUJNPF?= =?iso-8859-1?Q?BLB4ihlC+ReI9CPZgvAN5Pkf7FLFmAj+1TIvcUmC8ENrvXuIohvir8bxzg?= =?iso-8859-1?Q?ScvSlnTBAGyrpfHFNeGI1ryJEbTINBXnFLnu6c0+P5HGqPpNbFx3wkqmVI?= =?iso-8859-1?Q?c4eRRnMksBcrRa4/S64+bFC1g7LR0LqxhnJMVlueDNbVZoZ5NobVoyPUzz?= =?iso-8859-1?Q?AGXQzw0Ck5IOsFjWlDpNVv1m1WMxLyA68PNAeIaBdQiP3noAft2pqF4yT2?= =?iso-8859-1?Q?nethksdJ37W3IvuoMe+/u5PC2OMkv6hIbDwpvmoiHwYW1MhLhwW/3SbZ+V?= =?iso-8859-1?Q?uo/J7Dt8hRxCq829uEUTW0j4PEeBLP6SCa7wVxng7BSs0I0hKvaOdnic3c?= =?iso-8859-1?Q?tP4mB62GY7O7WK+QjuuKcU0We1kVtgZKtY0hqWnSWcGWAM9oaPuNJVCYlZ?= =?iso-8859-1?Q?+u7P+TzmXiI4RdwhlL4M3JpKy/vOjgNqImdePiaVq+kkpi2RUYc4Cms+zo?= =?iso-8859-1?Q?oCp3+6KwepjAjMC/Aty6PmCAeOqo5UlOnHy2znzGKEn2/8gansgim2LHE0?= =?iso-8859-1?Q?BXmbOQVkY5nu3WqXKMx9xvEqfpDyDb1J7+oGPJHESBaTJiPyMa2+Mr12CH?= =?iso-8859-1?Q?NQRf1PLEr2Mir+C0kO+cm2m2kgK51CasCjNvcsDlRS72PSV3MqMMflxybx?= =?iso-8859-1?Q?sPnnMJ7/IlFUCDHCexduhVAR+n/JdUoCuL2GpIDYw/756VptWN/NfxKGcQ?= =?iso-8859-1?Q?tXWTddD/tkKFzawFCmYIqZcsuyDyaJCPejmCbrHkLVGzfSYeb+1aeiwez+?= =?iso-8859-1?Q?wdzjg/J8wr4igNlGB+smYrpRH08A3TG4SEwV9lfSbYDMY5CRICdh1vTGvN?= =?iso-8859-1?Q?JQP4FQFRzm6enyhQMcepQuLqQZscK6fFcB4MujO5AEjeJtKy/I3BnPWHZK?= =?iso-8859-1?Q?s88ghDCM01vFiI4UnrcdMN8LBtr4MNPRshmhwG1xmhCd+ekaXM5z8z1iW4?= =?iso-8859-1?Q?lTykhmEIKwM0LL3jHqLn/cb5Va6Eh2/q+MXiFPVHZ8RTq1v4ZSNPZg81Ai?= =?iso-8859-1?Q?ossBZl0SdnBomAlXuN38fePRAcWZu5u7WcGaIH+BGraC/bmX1WN4atUMRP?= =?iso-8859-1?Q?EdLWPP+diBEW60rBb/hu2C4XThfm7fuaOUaJzmyy2AtI3hxTAoFP/b5FjI?= =?iso-8859-1?Q?vQL0kZ8UDuKTMPNDhalqKp6oHTASUv3vFc8elAM6YMm157YnL7jbUVRq0i?= =?iso-8859-1?Q?hpvMN/lZXxtwueRfIxqPSgknm3a28HpmqIQDNmsx9ROiPyPLkReuJZrGZM?= =?iso-8859-1?Q?xn/YIvID2jb2bs3wf3DEbqOOSim+K36TAHn2C/uU4zEGgq+lL70lMRnqjh?= =?iso-8859-1?Q?Bj0Mvs0iJXHf2doCVoz+6NYpLRC8DA7MqglRkRQkMqYHq+6b5YYC+QPeem?= =?iso-8859-1?Q?pbX51vdPaUl73lvmaFtKdTX9qPuLhJbC1x3TQL/sv9pkpSZ8dK1Ea0Zlmj?= =?iso-8859-1?Q?4H1KQgW+NgW+c4NnZNLajl?= x-forefront-antispam-report: CIP:255.255.255.255;CTRY:;LANG:pt;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:CPTP152MB4022.LAMP152.PROD.OUTLOOK.COM;PTR:;CAT:NONE;SFS:(13230040)(376014)(366016)(1800799024)(38070700018)(8096899003);DIR:OUT;SFP:1101; x-ms-exchange-antispam-messagedata-chunkcount: 1 x-ms-exchange-antispam-messagedata-0: =?iso-8859-1?Q?DI+vMNp/QBEHCu/QXCHS7oUMyHMCTis3erafnTR4JFsYU0zQiZp0aUKMn1?= =?iso-8859-1?Q?Ac5OnAKabBfU2kXDQDZfx/P+Wz4zGCv3j8lyfytf5RUktnZTmxyI0fw83o?= =?iso-8859-1?Q?cXKhHlx9cg5cdR4/qepXafRRYbJraOVVbAFprQBMXwAkEQsjSxp/jDEJQM?= =?iso-8859-1?Q?Sk+LDgTT8FxVSzSuHBPrtCzHT5mzB+evejwlfkJqejk2c0joia8dnYKgGu?= =?iso-8859-1?Q?VZ/YxR8vdN0oAwIJy4D6ydhUXDlIxfcKF8a/p6o3Y7uuuGNZteT7qX8M4s?= =?iso-8859-1?Q?a7/NtLLSZ0jkDWKTIfg634X/hYGD909sVySCHWjZC3Z55TX0CKzfTvrrme?= =?iso-8859-1?Q?mY6Lrr88DtCxyxD2/XU9JWo9VswrcD6Vw1rAeDZdz5QLddJuKesszwDnNw?= =?iso-8859-1?Q?RUhlEm0osZpus3xUoK/S0EmEHh8Z3cal9g2Hsk8hp/PhhgZfWW+vBx78uV?= =?iso-8859-1?Q?smRxPEb62NWVSY94tPgh3Gb/FYGRha0YOeT/xr8vYyAuma3b+jbf+Ux/Oj?= =?iso-8859-1?Q?iSJOJJvfx+t7qXNL+KDcZpfEBNCY0T/8uFr1gflf5tGckRToHO3St0VGfF?= =?iso-8859-1?Q?6yZkpPrzbfqQP0FG5/Gvvav2DqWyAkKFAiigyiNp1o7LEN4m9edhGtmoQr?= =?iso-8859-1?Q?MgiiQjWLHEllKVWWxJK5ZKW/xCqdGdTM9swpaKY0QHSvNPZFMw4IOHiPZ9?= =?iso-8859-1?Q?ST+ZsQi7PyWrY+AbQjn1LvJSBkzpJeptPO3XXn23x1FVSDjlXYjba/UVI4?= =?iso-8859-1?Q?hQaqqsWt6PcF5+a2c6jcyNSwoglHO9noYGP7KJDuEMSKc00zWT7DM/+Fgi?= =?iso-8859-1?Q?/fov8CHjhKNNxK7Eb2G1Gv/8yY/wgi7ofAmRzupun6xR3kq5ZJ/jHoVuCK?= =?iso-8859-1?Q?wahL5A0hNcnQrzXebRWy2IxG9uQRWorA5I5ysex9Wix/1Sjun9D//pprbe?= =?iso-8859-1?Q?OetOIwdfojpuBvDA76662f+RIp0DcYrNmkRxS9OivA+akR0XvZJLAgFc8n?= =?iso-8859-1?Q?tDWX0yxHQuBdN7VrmMJ0/z5KiLGVt5UdK0bzzFvlxwizlyMUIgavvsXhN8?= =?iso-8859-1?Q?inIDOBbnmouiTGxZy+Akq7VjWPb5wi6+00Q+oDLteZ7bW6WuudzbbVpuDR?= =?iso-8859-1?Q?t6mdZy2plwOGncE4sPEswD+efDNZkP5PyZcjjaspxdHLl7JlBSZcWGXHzj?= =?iso-8859-1?Q?F7s1T/sJSK8P0R133XXSAAurKgujHaBFJZnsqMmFtMkGTpCCNw5Cz1y4LI?= =?iso-8859-1?Q?RZ9Bxk1hpq1bkN7FV0XvXdeA5gSu5iI8qOhvDpBe9pMnHH2bR4db1w5xnw?= =?iso-8859-1?Q?P6KhWeoNQrSTJpf9j1ypgwO1prHxxoZl0uix5hQ7dHeEuQmYkYyrWZervK?= =?iso-8859-1?Q?dnALITn8a9MTHNhm8StUC+WiE99oWsmU6MwJsTjsH8AwssigEYGDJONX6d?= =?iso-8859-1?Q?BUn2rWPOPJhtuRG9gzugPYVFGHeP+IVnL3eFAPXOklfA5cKVsWvLxOV16o?= =?iso-8859-1?Q?lxO3HTMFaX9bZK7g20iCZRxn9eF6YXFBqbMpwceGvmottiaKI09qnG64Ie?= =?iso-8859-1?Q?A2WpCTnokXWjBAWGK/c9G53E556jkskmwKGebJfPFSxr0fYQud8JoIKOP+?= =?iso-8859-1?Q?IxCLWj3d3LWzn7sG7Em7gPsFHgPf7N/52R?= Content-Type: multipart/related; boundary="_004_CPTP152MB4022A37CD5A128EFD6BF7419C3E32CPTP152MB4022LAMP_"; type="multipart/alternative" MIME-Version: 1.0 X-OriginatorOrg: hypera.com.br X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-AuthSource: CPTP152MB4022.LAMP152.PROD.OUTLOOK.COM X-MS-Exchange-CrossTenant-Network-Message-Id: f7b72a6a-46d9-4ed0-afc2-08dd3c9df6a2 X-MS-Exchange-CrossTenant-originalarrivaltime: 24 Jan 2025 17:38:50.1513 (UTC) X-MS-Exchange-CrossTenant-fromentityheader: Hosted X-MS-Exchange-CrossTenant-id: 3f7a3df4-f85b-4ca8-98d0-08b1034e6567 X-MS-Exchange-CrossTenant-mailboxtype: HOSTED X-MS-Exchange-CrossTenant-userprincipalname: RioEJzmDQx6Vqqo8wYB9OeQrAVBUu6n1lhyYV19MYv3XB/SPqmd0cPm/39T4FQbuyUSyd9caWu1vsaGx+rFluY3bAEPyFbTT5QoGw6DILWU= X-MS-Exchange-Transport-CrossTenantHeadersStamped: CPWP152MB6359 X-Spam-Status: No, score=1.0 X-Spam-Score: 10 X-Spam-Bar: + X-Ham-Report: Spam detection software, running on the system "cloud.mkt.tools", has NOT identified this incoming email as spam. The original message has been attached to this so you can view it or label similar future email. If you have any questions, see root\@localhost for details. Content preview: Oi Re, boa tarde! Tudo bem? Poderia por gentileza, nos ajudar com a criação das artes das mecânicas do mês de fevereiro para o Clube de Craques? Serão 2 conjuntos de mecânicas diferentes para cada um dos cargos (Vendedor, [...] Content analysis details: (1.0 points, 5.0 required) pts rule name description ---- ---------------------- -------------------------------------------------- -0.0 SPF_HELO_PASS SPF: HELO matches SPF record -0.0 SPF_PASS SPF: sender matches SPF record 0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily valid 0.0 ARC_SIGNED Message has a ARC signature 0.0 ARC_VALID Message has a valid ARC signature 0.1 DKIM_INVALID DKIM or DK signature exists, but is not valid 0.8 BAYES_50 BODY: Bayes spam probability is 40 to 60% [score: 0.4999] 0.0 HTML_MESSAGE BODY: HTML included in message 0.0 KAM_DMARC_STATUS Test Rule for DKIM or SPF Failure with Strict Alignment X-Spam-Flag: NO --_004_CPTP152MB4022A37CD5A128EFD6BF7419C3E32CPTP152MB4022LAMP_ Content-Type: multipart/alternative; boundary="_000_CPTP152MB4022A37CD5A128EFD6BF7419C3E32CPTP152MB4022LAMP_" --_000_CPTP152MB4022A37CD5A128EFD6BF7419C3E32CPTP152MB4022LAMP_ Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Oi Re, boa tarde! Tudo bem? Poderia por gentileza, nos ajudar com a cria=E7=E3o das artes das mec=E2nic= as do m=EAs de fevereiro para o Clube de Craques? Ser=E3o 2 conjuntos de me= c=E2nicas diferentes para cada um dos cargos (Vendedor, Supervisor e Gerent= e) totalizando 6 banners Ser=E3o 3 artes de EANS sendo eles, Rivaroxabana, Neogermina e Vitaminas Ne= o Qu=EDmica Os EANs s=E3o: Rivaroxabana 7896714290799 RIVAROXABANA MG CPR REVEST 10.0 MG X 10 7896714290805 RIVAROXABANA MG CPR REVEST 10.0 MG X 30 7896714290812 RIVAROXABANA MG CPR REVEST 15.0 MG X 15 7896714290829 RIVAROXABANA MG CPR REVEST 15.0 MG X 30 7896714290836 RIVAROXABANA MG CPR REVEST 20.0 MG X 15 7896714290843 RIVAROXABANA MG CPR REVEST 20.0 MG X 30 Neogermina 7896714294315 NEOGERMINA CT 10FLACON 2BI SUSP 7896714295824 NEOGERMINA FLORA 1BI CT BL 12 CAP DURA 7896714294322 NEOGERMINA CT 5FLACON 4BI SUSP 7896714295817 NEOGERMINA FLORA 1BI CT BL 6 CAP DURA Vitaminas Neo Qu=EDmica 7896714265933 NEOLEFRIN CT BL 20 COMP 7896714273822 NEOLEFRIN DIA CT BL 20 COMP 7896714214566 NEOLEFRIN DISP BL 200 COMP (50X4) 7896714293370 MAL BRON+CL FENI 2+2,5MG/ML SOL GTSX20ML 7896714293387 MAL BRONFE + CL FENIL XPE CT FR X 120ML 7896714295077 MAL BRONF+CL FENILE BL X12 CPRV LIB PROL 7896714219318 HISTAMIN 2MG/5ML SOL FR VD100ML Sobre os banners: Mec=E2nica 1 - Vitaminas Oriente. Banner 1 - Vendedor Premia=E7=E3o por vendas faturamento (R$) de Vitaminas Neo Qu=EDmica Ganhe 5% de comiss=E3o em premia=E7=E3o mediante atingimento da meta valor Pr=EAmio limitado a 600 Neocoins Verifique sua meta no app/site - Colocar no rodap=E9 Banner 2 - Supervisor Premia=E7=E3o por vendas faturamento (R$) de Vitaminas Neo Qu=EDmica Ganhe 5% de comiss=E3o em premia=E7=E3o mediante atingimento da meta valor Pr=EAmio limitado a 600 Neocoins Verifique sua meta no app/site - Colocar no rodap=E9 Banner 3 - Gerente Premia=E7=E3o por vendas faturamento (R$) de Vitaminas Neo Qu=EDmica Ganhe 5% de comiss=E3o em premia=E7=E3o mediante atingimento da meta valor Pr=EAmio limitado a 1.000 Neocoins Verifique sua meta no app/site - Colocar no rodap=E9 Banner 4 - Vendedor Rivaroxabana Premia=E7=E3o por vendas faturamento (R$) de Rivaroxabana Ganhe 5% de comiss=E3o em premia=E7=E3o mediante atingimento da meta valor Pr=EAmio limitado a 1.600 Neocoins Neogermina Premia=E7=E3o por POSITIVA=C7=C3O de Neogermina Ganhe 400 Neocoins mediante atingimento da meta* (quantidade de pdvs positi= vados) OBS: Colocar esse disclaimer: *M=EDnimo de 10 unidades por loja Verifique sua meta no app/site - Colocar no rodap=E9 Banner 5 - Supervisor Rivaroxabana Premia=E7=E3o por vendas faturamento (R$) de Rivaroxabana Ganhe 5% de comiss=E3o em premia=E7=E3o mediante atingimento da meta valor Pr=EAmio limitado a 800 Neocoins Neogermina Premia=E7=E3o por POSITIVA=C7=C3O de Neogermina Ganhe 400 Neocoins mediante atingimento da meta* (quantidade de pdvs positi= vados) OBS: Colocar esse disclaimer: *M=EDnimo de 10 unidades por loja Verifique sua meta no app/site - Colocar no rodap=E9 Banner 6 - Gerente Rivaroxabana Premia=E7=E3o por vendas faturamento (R$) de Rivaroxabana Ganhe 5% de comiss=E3o em premia=E7=E3o mediante atingimento da meta valor Pr=EAmio limitado a 600 Neocoins Neogermina Premia=E7=E3o por POSITIVA=C7=C3O de Neogermina Ganhe 400 Neocoins mediante atingimento da meta* (quantidade de pdvs positi= vados) OBS: Colocar esse disclaimer: *M=EDnimo de 10 unidades por loja Verifique sua meta no app/site - Colocar no rodap=E9 Abra=E7os e obrigado! Lucas da Mata Lopes Hypera Pharma - Similares e Gen=E9ricos Trade Marketing - Canal Indireto lucas.mata@hypera.com.br [cid:image001.png@01DB6E6C.394A3710] --_000_CPTP152MB4022A37CD5A128EFD6BF7419C3E32CPTP152MB4022LAMP_ Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable

Oi Re, boa tarde!

 

Tudo bem?

 

 

Poderia por gentileza, nos ajudar com a cria=E7=E3o = das artes das mec=E2nicas do m=EAs de fevereiro para o Clube de Craques? Se= r=E3o 2 conjuntos de mec=E2nicas diferentes para cada um dos cargos (Vended= or, Supervisor e Gerente) totalizando 6 banners

 

Ser=E3o 3 artes de EANS sendo eles, Rivaroxabana, Ne= ogermina e Vitaminas Neo Qu=EDmica

 

Os EANs s=E3o:

 

Rivaroxabana

7896714290799

RIVAROXABANA MG CPR REVEST 10.0 MG  X 10

7896714290805

RIVAROXABANA MG CPR REVEST 10.0 MG  X 30

7896714290812

RIVAROXABANA MG CPR REVEST 15.0 MG  X 15

7896714290829

RIVAROXABANA MG CPR REVEST 15.0 MG  X 30

7896714290836

RIVAROXABANA MG CPR REVEST 20.0 MG  X 15

7896714290843

RIVAROXABANA MG CPR REVEST 20.0 MG  X 30

 

Neogermina

7896714294315

NEOGERMINA CT 10FLACON 2BI SUSP

7896714295824

NEOGERMINA FLORA 1BI CT BL 12 CAP DURA

7896714294322

NEOGERMINA CT 5FLACON 4BI SUSP

7896714295817

NEOGERMINA FLORA 1BI CT BL 6 CAP DURA

 

Vitaminas Neo Qu=EDmica

7896714265= 933

NEOLEFRIN CT BL 20 COMP

7896714273= 822

NEOLEFRIN DIA CT BL 20 COMP

7896714214= 566

NEOLEFRIN DISP BL 200 COMP (50X4)

7896714293= 370

MAL BRON+CL FENI 2+2,5MG/ML SOL GTSX20ML

7896714293= 387

MAL BRONFE + CL FENIL XPE CT FR X 120ML

7896714295= 077

MAL BRONF+CL FENILE BL X12 CPRV LIB PROL

7896714219= 318

HISTAMIN 2MG/5ML SOL FR VD100ML

 

 

Sobre os banners:

 

Mec=E2nica 1 – Vitaminas Oriente.

Banner 1 - Vendedor

Premia=E7=E3o por vendas faturamento (R$) de Vita= minas Neo Qu=EDmica

Ganhe 5% de comiss=E3o em premia=E7=E3o mediante ati= ngimento da meta valor

Pr=EAmio limitado a 600 Neocoins

Verifique sua meta no app/site – Colocar no rodap=E9

 

Banner 2 - Supervisor

Premia=E7=E3o por vendas faturamento (R$) de Vita= minas Neo Qu=EDmica

Ganhe 5% de comiss=E3o em premia=E7=E3o mediante ati= ngimento da meta valor

Pr=EAmio limitado a 600 Neocoins

Verifique sua meta no app/site – Colocar no rodap=E9

 

Banner 3 – Gerente

Premia=E7=E3o por vendas faturamento (R$) de Vita= minas Neo Qu=EDmica

Ganhe 5% de comiss=E3o em premia=E7=E3o mediante ati= ngimento da meta valor

Pr=EAmio limitado a 1.000 Neocoins

Verifique sua meta no app/site – Colocar no rodap=E9

 

Banner 4 - Vendedor

Rivaroxabana

Premia=E7=E3o por vendas faturamento (R$) de Riva= roxabana

Ganhe 5% de comiss=E3o em premia=E7=E3o mediante ati= ngimento da meta valor

Pr=EAmio limitado a 1.600 Neocoins

Neogermina

Premia=E7=E3o por POSITIVA=C7=C3O de Neogermina

Ganhe 400 Neocoins mediante atingimento da meta* (qu= antidade de pdvs positivados)

OBS: Colocar esse disclaimer: *M=EDnim= o de 10 unidades por loja

Verifique sua meta no app/site – Colocar no rodap=E9

 

Banner 5 - Supervisor

Rivaroxabana

Premia=E7=E3o por vendas faturamento (R$) de Riva= roxabana

Ganhe 5% de comiss=E3o em premia=E7=E3o mediante ati= ngimento da meta valor

Pr=EAmio limitado a 800 Neocoins

Neogermina

Premia=E7=E3o por POSITIVA=C7=C3O de Neogermina

Ganhe 400 Neocoins mediante atingimento da meta* (qu= antidade de pdvs positivados)

OBS: Colocar esse disclaimer: *M=EDnim= o de 10 unidades por loja

Verifique sua meta no app/site – Colocar no rodap=E9

 

Banner 6 - Gerente

Rivaroxabana

Premia=E7=E3o por vendas faturamento (R$) de Riva= roxabana

Ganhe 5% de comiss=E3o em premia=E7=E3o mediante ati= ngimento da meta valor

Pr=EAmio limitado a 600 Neocoins

Neogermina

Premia=E7=E3o por POSITIVA=C7=C3O de Neogermina

Ganhe 400 Neocoins mediante atingimento da meta* (qu= antidade de pdvs positivados)

OBS: Colocar esse disclaimer: *M=EDnim= o de 10 unidades por loja

Verifique sua meta no app/site – Colocar no rodap=E9

 

Abra=E7os e obrigado!

 

 

Lucas d= a Mata Lopes
Hypera Pharma – Similares e Gen=E9ricos
Trade Marketing – Canal Indireto

lucas.mata@hypera.com.br

 = ;

 

--_000_CPTP152MB4022A37CD5A128EFD6BF7419C3E32CPTP152MB4022LAMP_-- --_004_CPTP152MB4022A37CD5A128EFD6BF7419C3E32CPTP152MB4022LAMP_ Content-Type: image/png; name="image001.png" Content-Description: image001.png Content-Disposition: inline; filename="image001.png"; size=8504; creation-date="Fri, 24 Jan 2025 17:38:49 GMT"; modification-date="Fri, 24 Jan 2025 17:38:49 GMT" Content-ID: Content-Transfer-Encoding: base64 iVBORw0KGgoAAAANSUhEUgAAAPAAAABFCAYAAAB0UmtUAAAAAXNSR0IArs4c6QAAAARnQU1BAACx jwv8YQUAAAAJcEhZcwAADsMAAA7DAcdvqGQAACDNSURBVHhe7Z0LqFVVt8e3IBGCeQmvhBgUIYoo mNfAyEiKEqNQFDXRukYqiqSmJurBZ4opvkqrT8VHpuZb84kePUq+EF+oRCkpqKgYN+lGEV37Gvf/ m3NNzzrrrH3O2ec7R7+j6w+Dvddcc84119rzP8eYY465ds4yZMhQ5/DPf/5zQw5ExxkeZBQtNBs0 RTK9bsnAaWZDZ5jNWWH2d3Qvi7aY9S9Kz18nRPeEjJlvtvdUdFOFIyPww4Qn+5rl2kheqIPyvKSd 2WOdzXac8PfTuLvS2sby1EV5TqL7eneyv6cCkRH4YUL7weosL0veqMPSyQvYf07fIXZavrokr0s0 sH4obVwgMgI/TKiUwG9KXpFAiiAck56W/35Je00HPvP31KyPjl9NnK+LIssi91rpFKGKyAj8MKFS AqsDPT/UbIDmZkGeH+LTU/PfL5EG7jzS39MbH+r4pcT5uioyp/ee9vdVRWQEfphQKYE1n1y5O8oc YfkOn56a/36JCPzqB759Xcfo+EEhsCyeLYf8fVURGYEfJlRK4GfNlm2LMkdYstWnp+a/XyICvxZp 4DcfJA0sAn9zxN9XFVFjBL4qGfq7WacbZi9Jet82m6q0Enc2w78FyhEY5wme0DDfbSbCfhNljrBw ndKfiOVBmBd3kXSMpSEvSkiPd8ognAv5uCbz1nAMAUM52sRxRXVlBA6oEQKLt9bqilnji2YtL0v0 /Rl9NtFx4x81TfnJbL3PmuF+ogyBRY7He/m14Y+WeBmiITdpQp+5pjzzNRov9nlmrTR7a4JZvTfN eo7zzqRpS309Xcf6eh0pISLX4VNpQ2b48lMlEz43e2WE2RTVOeYTkVHmsBsUROz6qvddtYP8j7FM FOqJS0bggBoh8ERJI5G1ndTwsynyzCWdv2DW/3/N7vgiGe4HyhBYhHl2UHQihk2VzMFOaXT+bKOZ LKxU/CIZMUv1o2VxfkFoXetXf/ou5q6OvkQ4J7Otq0jZYYjvJH9J+ovITssnO3pG4IAaIfBrt8xa SOOmkTcuT0gbP6cBXVzPcD+QJHDbgdGJGDZ+G31JwVd7zL7cFR1UglXK64iFqaxrXcdOi2HmiuhL AhsOmu057QlNBFZG4ArxLxNYStWai7xtUgibFDT0U9LGfJdVXSF2XDebse1/bbPqrgirvlO+Hb/a vsoqzKAfIEHgdgVo4FP60fBIF4JFOMDa+2tdSxB4zlfRlxSs2CltLBMbc7ogExptz4CB5g/l+B7S 4nWQFwnH5Fc7nXDMuixpfIY8tS0i8NZ7TGDGYzRr24ikeUWaF2knaab8XaS1K8Lj005YbvAuazj1 WJSSjtzYg8q321rOKmz97KFEGQKrQz/ZzxO25LyXJRvM1hRHmWPYulej5PLoIIELGjn3HDe7krSR I/TQPJlQwSSBP5hjtvNwedM6oFlvlRNRy3VyJI3AIltDzZmf0z22HaBjiCiCPv22Wceh0hy617v3 DjEDwcN35e/4vs9bT+mP9zR7tKtZ415Rvnsh94HAkyQQOJW0iDRpO82X2v+sZ3vTf7bXPKmRNPHH vopUtJx1xnJjDljzSohZf/JRl+/5+eqAGSpGGQIjdFxMVOaryJPlvdCf4oVuYHZeP14S/fXr0+lc PK/KD/ooOhHDcf3QEPjKb1FCBMiSaykRGacvjRJjWIz2pt54Bw+SRmDdx5xVZod+kFY56U19Yr+/ k6b45qjZWXXE4czNyat6P/laZp4GnlwHdSJpWa5HuSMXzHoVydqQFfCe7merBhnIfE808X0gMBq1 9ZUU4kraiaztdK7lxkv2xKwd9vRHG+yJ2TutleziNkpvoT7xR1RPEq0iAreohMCPRAR+4ZOMwJWi HIGDBC30rNnSxDowBG4kzZZE/ynKz8YIylEH5qiOh6QMy2i/C+oMcbwsE9mRCdO2tXeMxYHCrpc0 c4OkEVgDyCpZCsQTvzTM7EdpCbzixzUHg9xva7D5Th0O8j75VumcvJMGkoYy1cHw2b6ehmrTMWkl nHF44Z0WfgAJPP7v/Nq3vbRu68N/WZNxKy3Xfbrluk4r89mkaJU1Uls/iepKImjg6hAYB2Y+J2lA ij65C5yg1fGWa0wyjf8F43s1WPohFeit83rOlbgCqoa8BA6SQmC8xZ1HRwcRbvypvGnrtHRymaI6 XQbdZEZDhDjuEphyatMz70QnYmje39dX5hpIjMB3QylFPKwHNO4xaX2mBE+rTjrC2hL9MDL1P16h fM01KK332pqtfGhdBp5RIi8e9NUaBBrpPkrOmb0/0xPZaeDkHLo2BAJL4xeAahN4iaSJ7g1Nyhow 675P6rk1k7TWs2pV/Is98u58y3UTYfvOsly/2aXSe6YG7imWG7bIutHrU1BdAt+Q5MZ/q7r3WtE2 XGzl0WzGSXf+vZW+U2EFDNb3DnPPWf1Jqo95NVJ0yJ6bc9aKttwu1ycDvpe8vfSyPTLxiOU+PCAp ceW6LPjeNur5JNFJ7Ww06YhN2/O7jVh/y+pNPOzLjSh2DjkwbO1NazPztOUm6JzuzZ3nU9d4feH3 Vlxdh111CExHZ102DsxUZzqn1SENB4niwBRl+SmOMgQWOZi/JvEiZnZae/MQmDVsLIN6Oo8Xe6is AUz/0XO9t5VzDWQxgMMylYPHt4sGKMJFKQeJWeveIiJhckNgZ2Vwv2nWQE3KPSLwDEkD3T9ruxC3 o9RHH934SPVyzR6sr7jUYPDnVq/HDKvXV2TtExEYIvdUWv95krn63Sba45/sSyVHIHBlzqkkgaFk bvwhy43eb/2Wlx8d8Jk4Yowusd4iHhi39bblhu6x3DgRXwKJH50SEXnkfsuN2i/SHbUTCXv/rDSn GyxUF8RlPt4E5xvlVCY3cp/NOlCqy7+m34/Y5wju69Z38nGsAWX5Ge+dz7273Z9TOxt9dNyemK46 GSBiZD6e8AlVCdUisDTw6yJJHDcL1MCYstXRwKSl7jTKp4E1j0VzrtL8d68eJnnQxLQV8u48YTZT 5FwnjdxZz6KLZKG0MWRdXazym9ROdWY22pPGMhb3imm+bLu00ruqK609NSW1TGB+2leYRkhTdNOU hg1daKAk3lhwXh1trzUYv8cajvzaGgxYYPX6fGy5HtOt6Zzd1uasNLd42WTSWnXW+Za2cOEIrE7e VNpyj64JWU6JQEHO6XidBpCgMeMmtPNgq6O/LG2VBCauI4xIN3yd1xSjN/6k/J5Ii2VRBZwW9/ou veTJNvaANVW9ceA4c4QS6afuLnXSHNJo33rmqajcQWcVANrr8kNGpXdU+TVqIor6WMwbO0vamXuO 2w9wYowsATfIaLB4O2VwqhTVIfCnazUH7B0dxNAPB1Z8Dsyn5rJEUCXxVF9vwsbRKRAY0rcSkTZE JyIw7lVlDnyXwLp+U81t2dzQjYgw2qOybhDgnjtobjdQHfgDafseOmaDhu6XrZIvDFU+mevDpHHx QmNFYL436ObPDZAFAZmb4BmvTS1cwwSeqF7TWX28Bx5kDaAQ9w0d74nOp2H0hluug+UmHZMct9yU EzIvD9mjQ1dY/YlrrZV6M57odtLYbdV5cwMX2srQw2NwBEa70dnptBEZygjp0fk4gV+W+YqWQnsl ATFc+6ShJ273FBm96Wd3DIFTmmLd/nHRX09acVlkEDCIODIqvdui8rbyblUE6dGw0/d6dbn+YmmZ rl+IzdVAsxkanHRv7WTaF4zqEJhX1+RamF1NUfm9IQqmpciB9CcmL4GD6jR4ty9im8bQRmRyXmiR jzDMJJaoHa7etHamEVhpEJA5Ld7lwRpIHulqtkLamKUyAlRav6d8eN1VL8tY43Vd7pmQUgJINisf b/tgyWzsAj8YEPpZX/Wg4euaCd1p90/WVB3xSfVPnFVfROn5MGvfn96chFRlRFqy6LAt1Py4j0ZW gjkI6oDE9adsskUny7ucMJ3vEhiTN02YP3I+QeBxW3/x7Rh30M4kvFELj+o5OZP3gC2TlQWcBiZN BP4uZUP1DgavyHxlfgrQ1L6eEluS55VGDCAMDG9FpjpzYkdgmeVflB9bqoQO89D6JdZmdtT4QkDg RqEEdruRmvn5ZBowjb+WiYmHNw0T1WtWJpamwG6NhBv2md3Os4O9LWTL19Y0Aqvzr91vNv9rv4/5 qiwiNDHz9Y4DvANrj34oyNtARAzj0eMiJ17odzT4DIxeawOBd+sHxqPNHLolpvM9cmJhuheACgnc edZWa6YpRQtp3ZSfoAw+Lv7Dd+hAqriIGE9ML7VNn9c0o4UsQNaH60/bbMt/SLBMcASWBnv641OW cIncxWlZCGle6E0aILyWLbG5B/FJl2LgV9c8GaUFg96sjMBc3w0maM5I28799i9/DQ1MmOoDVl2z d1dedTJA1+iz7LLVm6R7F2E7fuK9U1vE40DghRWsFtC3pso6eHXhD9Zalgjatv+X12yertkc55ae S9s595LA0Xuntmr0KwREbiUdWlXBxM91vXzaF8kzB6btkHSV5rP7ZKGgcVmHHiFtjEbfJC2MNcGg sliWBWmzVymtnU9nPryNtWFNBXarHrQ0zq4WeMPrIIH7TflKHW6lTU04b+KAegNXihR05jTyItKQ nRZELlaBLtJEBG4jE7r+h8stJfbHE1hEK9SJFVAf8ii9U2Ie/IwGBNKf0Rw1oDICO8dXROAun3vT d/6hiMBch3N8T4rq4zM40/zAUjGBWU5qTJ04txC11Q0EXGN4sa+z6Nt7TGCl47x5VPNVzNOqAMfP tgIJD+Z8qWthroa5dZrkITADBtqz33izExot+0zwFgJkBW7Xk0xoxvT1MpnXSGMD6sPCYLBxdTU3 K9YAMFIERoM/xpyZkFDm64R3prWpJqSGCTx7vUzAjuPttZn7bYMUT7xv40Sauus3azxVc106ZRpx g6jjJ50uvVTZ418ctgZjV6YGcwQCV7SMxO9wl8CJSKy3pAFdu9TxxRuHI5ryunmpSPV+ZAqDUTEC ny+rsB1OSdNzD1wHDQ7mHLzj6iF9ys5fnZbWrKCcBC0P1uGFjgi84Ei66Yj2dsTVoMc8OT5T3q4K m0zTb6J7aFMrBJamZcNCHEQ0OQ1Mx8UDqw7OnDW9+X4Z5ovNemjcfQHAydVXhHOat7K5Zh4TmjVc tOhQmdDU9+5Hfu6LdiX2Gu8z817M4kkyjyfNkxmndrJODFzZKWY9VPe3Gvgh8EWZiWjs4TMjTQyJ 09pUE6J7YB5eACok8BkGpN4fW72xO9V5pQFExubSXMQnuw4dtEySsElRxx8kEzOO2Xhku86wrvTK FPyrBP7GmateE06I1oNZd/VpB6w4ZtlVRuBPD//tylB2ksgKVulyzvGl9Ik78gX0lkVVCPw8c1w9 2/oyzdOCO9rNOefaUTsEFjH6ai74xSazBev8J1qM9Lt5IJdIRpww56YvM/tc+dgT3FOaD88t66cs u0CIBWv1ANdEDYhhjea/pLM3uMso1UnABg6meHvySRqBVf6tIn/dJRJisBt0995jSNeopyckZjHb KJ0HXQIp0dp4wYkGI4Ry7Ke+HHHVDFbLpNmXqk63Lp0WWFJTUsMEBi+PXWr1Rm6RqXjCO46cCVcF 0sYlprkALp22I1dLO67O6xj7VwkMXDimtBWBG3iAG7O8pLzPzdPEPoa7BB5/KJU0LTG7IzN5f7Qa QmCgS5OmbPrRcXdcGdYzaFVC4Bc1X6aNBIak5ahdAqNlOY8WVGdyn3TYNLMRTQThyBeEY9KpI6Rh eooolxJe6NZsOMALTR4IWIiHN43AtJG2Uh8mOIMOZjifnKNdfKdtWBKkIcxtw9tCKBfKIpThXEjn OO1Z1JSoDTVN4PWHLlmu/1LLTY6CCaoj6nAES4Bt4nFu7Lf2yIxD1iZuHyZQEwReqqKOmMFjzafa si2xhOoIrHQGphHrbrmtjKzLrtA0qL2IAkk53/HT0nk8GLlB5T7Y5843m37CZhT/YbtumB2Wwt8n Df+ZpoBvau7fMZqfb47NgfMRmOu7OqWFR8liSKIVTqwxJdZ8Vh7Xd0WolMC1IRBTxLqemCiVCeQo VESucgROy1fXpBYIDLrP2Cgi7PVru2kErUxkatKZ97A2OqLYei783ib+blbRu+gbM9cbuc995gOh E04LjtqX19nVQdrWETAKWey5JD4r9RgFESEwbVX7csN1rxAfImEma076lLR3mnZ+b8VVX5a876sc 81eO+Ryy23KDdtr4rV77fIXZTb6he212CaEZ5cGg9CyWA+WHF9tjmq7Q5q6LLvpnQruGFdsrKUEq leJ+EjihgN1bJTMCJ6SWCExXe3zUWpFFJCDyKUnQykSajXmk06rq3KekfKZX4NkGg2Ryt1CHZVmm IvRackn5TtiHm9KN2L039VyYr6sNj0oDl9dpZQmMx/idFVes/dxzbgnnjc9+sOmxKKs0lMisJoDl jc8vuPVZyqF1B3151dbEDAMcfx11voNMcjR0RVh6wmywyrefe9aFZzadccJ58oeuvmHzDtwp9P3f HlU2odnGh/mMGQk5MDOTJifnyBPMbCSej/OYz4i+Mz8eMdsHSHw4T2lcD7M1Xgf1huNg5ibbiKQR mLyYuJSl/eE+MX05pj0cY+ZzHObb8XKFmPG1IbVEYHDs6h1rOHqrtJnmv4WQWBqylTrtIY3ALkZZ 5mP3BUfsTNX8Pv8yir75xRNYGm3h0fRu7wgcObES1vWDhUoJrHPELRMM8ck6vwmBbXguHBFySvgn BBw8EHLeGuVb68MPeUmde2UPZBChIBYOIRxA7P1lw4C7fjTvZdmGrYfsdpqn67EtkOgprj1X9fK6 H0fqtHamEVhtI1aZ9uDIep0NCkrH67xM7WCPb33VxwCCQ2rEHF+GgYLdRrxwrxn/HUX70655L6QW CQxOS2s8VSSzkHkc0VVphC0j0tgyGZdEMRzM+8atu2HnkuZULYGwR9dWkbPH4vKmc8Aowj8jAp8v H1Py4KBSArfzSypHL5pNUAfvo06PpbT+gM5F2pQdP4DlGdYsZ6+MNtArHQ1LHeyxZc47Q6SY/aXZ 9zJR8FJfYh1PGnGa0jepLPXijZ4gjUzUFHuG2f2ER3jbMbNH0MJp68EQOHqx+10CK40ILDbqz1zh l4eKRFY+J8/3G/oH6zxrwuNn+va5Pc3N/UYG4AagfIPGvRARmGCTAlAQgQFztPe+OKkOr7niGJGj SCRNBnDgLIq03pjNVfHP1jxY862Pxlcbn05sQkgiTuBzVSDw77+nxAXXBVRKYBF0ubTTBhFrmLQh ZiWRTODZAWZPS0MByAD5MIUhKzt4IDQbGdCwaEFikHNPS1p4krIcwz5c9uqelJ3TtKtfZiJwpJ8G CojDFkCWsd6Z7AMwGhKDnKYR0wiMKYwJ3MxbDid0DWKg3Vs4GvoYZ7Qv5ykPgbEa0Pr8SRoBG2xc eNAJHLBfA1v/xeetEWvCOIkgMxLNN1+df94251d6tQr83c65NUyDjNqD+V4RBq+6Zrkhe5x5f6Li 6a7Dzp077cplH99cp1AVAkMotB/vgqajo5143cxyEZK3c3BMJyP4/4KeNCGHBE5AWsgAQTCDWRtm lxFhiWg9NCvzTsD+3NxT5jbgU98QledalzXqEoMM3od4zF/T2qm84a9V2Op4l8Ca27Khgt/wZWlT 3m5BMEeusSfzKF33EdXJWzomfe7jrW9JJfUapxFfVofbxVTR86ltgcB6rgWg2gSO44Tms1s0sG7V c9khYmscva9gej167U0bvvq683xXhn031Qe/vGLjtpS1Fv784w/75Zfy7C8pKbHvznvv1J075VX2 rZs37eqVK/brr+kT/Z9/ihaTI3B89aoe3N9+jn7j+nW7caN8w0O91bYA3LyyEhMaTUqMcIe3/NyV mGLmloyKvJiO7XhoUcxmt5sHh5CIisaFpF36e6L8JGJ00zy11xjvge4OOdr43TZufipiM98jkOMF zbG5Fpqd19cQHEL99UXUfCY0y1AgbkKHd3LxsvgnpUkZOIrPaF4vzcq+Xvb5npRmXyfroYXqYffS aWnqsLHfvf8r36BxL0QE3hBFhVURNULgBxEHDhywY0eP2oULF2zP7t126cdSc+LQoUNWsn+/nTt3 zp07e6Y0qOKnW7dc3tu3b9u+4mI7dTLSKMLuXbtc/qOqN2DH9u125vRpu6jrhPNc87CuwfeA6yI1 JKf+vXv22PfflV2TrhLcXlc6e1rnQaQhiVRiQwBxzOzgcRsLRCK0K84rtt4xh4W8jjyQTILGhHTb pb0xYannoMzSI3puENpdV3Nayrm5pszzcfoeykA6yMyL6HidLPuQm2gQyWtCR04sPl0bXvRleBcW 2hZLgoirAxpo0chYBURn3dKAyyAFsd0bM1WOWOd/bI4sFObdyevdK9EzKfDf+jMC5wEkiWPbN6X7 sfbv2+c0Ifjtt99st0zqNKApIXHArpR827eVbh5Aq588UTpf37kj/T3MWAW0oWA4JxPOKMzNtA5E Oh0YLc0nXtowJyQNQSOShkAuyqSVY0mI8+F7qJ9yzFXD9+S1qJ/zpMfbFoRyshRwioHGbDSgLOf4 pC59569f3HGohwGE9nCea3A+XAsJ7QrXudeittZXe3AyFYCMwHkQJx7YG9OGkOf6NR8aigldHCP7 LWnIg9LeZ6RVjx454jRpQHJQADulgQPQwnECo4H/ikz0a9K+1Hvu7Nly9VYZ7L2tT6euSAvTqZOS L09aWvxc/Hs8X/x7UtLyxUWDQXivFfNnt34bzlEmEDKUD2nhOJyPp4V84fu9FtqiKcXkxf6+CkBG 4DxIEnh7UgMzZxWYJ8cJ/M3WrfaLzGcAuTG1Ayoj8IUffihH4ADqvfOnj95C61dLAwMcOM340zA0 seZcdUqkeZ/p7Xc68SjqMRix1TEtb10RfAj6HJfv/awVIyNwHkC885rjQhY03/Fjpf8QgSn8YzQn /u3XX908NuBASYldvHjRfYfk8YEgbi4HbNmsuVcErnfkcOl+UMz24CSD/NcirX/58uXqEZh10uBz 21hiNm+15oZr6obMXWW2LnbP/BH2LJnRzG3T8tcFIRBm0Qaz69HSx8wl5bdzVoKMwHkAEc/KXMWs xSscx+2fy3qrMZvjYH6MNo07vkCYN8cRNHlA3MOcvO6VPPVWGTiIGslcY4vfzwVOtjLUDlh4YB2a 928RVLKu1GKrCjIC50E+x1SdRnu8rMQAY7p18nt3CR9s2qdmhDDLio6TEs4XUu6Jt/SJ6Hu+8vnS KkpPk3jeQsqlSbI8z/3uWy75PfBL6JMgmgKQETgPwjrvA4UygRw4bfDKQmgcQXwyH8NjzFoonYpP 5sqcC+f5JE8oE/LQAZmTxsuSFsqG/OGTpR88v+TBM0w6ZRDaSHq4Dmnhk7yc4zt1hPLxNvGdtvA9 Xpb85CWdNoZ2UAd5SKMs90l6uB/OhWsi5EFoJ3VE81hXhk+eR7heuFYoT5lwDY4hcHBmKV9G4Ax5 4d5EEQiMqIN2Gh69QnWsX8vtPMr/A3/vIv+GC9Zt+STyibBENjHw30MERRC5RF7Wit1Lz0VIjgdP N+s30WvLziPNrRfzT/5ETbGBgY0F/IMgFgB/6M2SD+vMlOEc67Js+Ke9lCO8kvk7nww8DERcm3Vi 8vD6WO6D9mOKupBIkYQ14p6qjxBP2u9eK6s2Upa1ajZQ0EbWpcM6N2UI8OBtHJCOPDwD7o9/qKDs 86qfazRSO7k33uBBxBdaledCm2kv75bmutTHhhDKcs+UZ0mPDR1uIA0ecBF4fRbIkSEfykRiSfsS 28xrZHq8bzbpHz7ogc7G61kJ5uAVNARZjBPBCZ3ce9qnEQLJPx+MmedDKN1bHreKiCIHGxxcWKVI THwx0VmfbdA1RvjXtDLfgxB8p8NPWSQi9PLe8TG6Nu+iojztIYb6nSme2LykbpTO87J3ylMPy0i8 t5noLf4OhXdeUY7NGC9pYKAM0V68mxrPNQSEmFMWe1KzAYN7wZlEbDfvwKY8+V9SvvYiPOe7i3Bc k2fDYEWIJvfGMS/vm6R7oA7ycp52EC5KcMgEkZnBgR1SvIuL9Wte4cNftrg47bAuHRF4bWHOyYzA DxOcZsKsiwj8zNu+gxPKCAmJUBok4kFWOjSaAi8vBNolQhMuiRbBUwpRB0rr8NcraGUIhDlIHXRi NOnZa56MvOa1g7QRmx+IkkLzzP7KazvevUVY5AGR5r3JPp0thudv+L9CIVqKfBCbTQ/11NnZ+gfZ Fqz3L69DA/PSOnYxDZ3pY7n5SxW2DUJ0iESkF4MF14ZEbJMcqHtlgEEbE8VF5BnRYDyTdtK4L+n+ 3XfNWSEd+dCcbJOkLjZl8Bx4ZgwIRH/10bOC0NwT54hae1NWAUQnRJQ02u7aedS/k/quGS2zemdh LwzPCPwwwW2kD5FYjPoa/el8C9Tx0RJoHzoiJiqmH6YyJil/SYJJiLnKy+wwk9ldhMmJ8N29sVEa GDMWbUU9rZSG2Usa+4sxMxkoIAKanONR+mT3EWYnaZismJm0C3OeTRHhGsMikxNC99KgwYvquA7/ nNBdREfbYTK/LHOaOnkJHfcFOTB3qYMBgTSsCv42FfMZSwBC0wYGnskiYDe8wjLD0ZK0vbOeB6Yy z+FFERvTm2kHlgb1Uo66EP7NsaXund1OtIMBjcGTARFTur/SCC+dqOdN9FX4LRroPgp8U0NG4IcJ P/2pTkJnwbHCiI/gXAkSnC2YdZja4RNnDo6XYO6hxXHAhHLURx4GBr6Hc+Qnb8gXnDx8p77g5OEa pJPGdzRS+B4+QznajPOLsjjhOE8aeYKTiPPk5ZPz1IeEa4X2kEYbqYfjUJ5rUZb7CXlDOa7LOcrw nfpDvdTFcwjnSQvlSAvnQz180nbytvbaukBkBH7YwPyuTT91GDyr7SRo5PBZm1Lda9yLtlUmtdWG UK/IXSTtXg1kBH5YsU7z0nmatxKNlcl9EubtMs8vlN1eWggyAmfIUIeREThDhjqMjMAZMtRhZATO kKEOQwTemBE4Q4a6i/UZgTNkqKP4+++/x2UEzpChDkLm8x0RuFVG4AwZ6iBE4EWOvCBKy5AhQx2A yMu7jP8jom9G4AwZ6gpE3p0ynZtG1PVQIvgrk0wy+bcS8H+S/5HsFnH/W3St51kbg060kzybSSaZ /PuIFO5/6bOV5D8jqmbIkCFDhgwZMmTIkCFDhgwZMmTIkCFDhgwZMmTIUDXkcv8PBqc2zRAILaUA AAAASUVORK5CYII= --_004_CPTP152MB4022A37CD5A128EFD6BF7419C3E32CPTP152MB4022LAMP_--